Health Catalyst, Inc. (HCAT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 30M 60M 90M Q1 '18: 20.6M Q2 '18: 23M Q3 '18: 32.9M Q4 '18: 36.1M Q1 '19: 35.2M Q2 '19: 36.8M Q3 '19: 39.4M Q4 '19: 43.5M Q1 '20: 45.1M Q2 '20: 43.3M Q3 '20: 47.2M Q4 '20: 53.3M Q1 '21: 55.8M Q2 '21: 59.6M Q3 '21: 61.7M Q4 '21: 64.7M Q1 '22: 68.1M Q2 '22: 70.6M Q3 '22: 68.4M Q4 '22: 69.2M Q1 '23: 73.9M Q2 '23: 73.2M Q3 '23: 73.8M Q4 '23: 75.1M Q1 '24: 74.7M Q2 '24: 75.9M Q3 '24: 76.4M Q4 '24: 79.6M Q1 '25: 79.4M Q2 '25: 80.7M Q3 '25: 76.3M Q4 '25: 74.7M Q1 '26: 70.8M Q2 '26: 70.5M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 15M 30M 45M Q3 '24: 36.3M Q3 '25: 40.1M Q3 '24 Q3 '25

Operating Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q1 '18: -11.9M Q2 '18: -18.8M Q3 '18: -16.5M Q4 '18: -12.9M Q1 '19: -11.1M Q2 '19: -9.4M Q3 '19: -20.7M Q4 '19: -13.7M Q1 '20: -18.1M Q2 '20: -15.6M Q3 '20: -23.5M Q4 '20: -38.9M Q1 '21: -24.3M Q2 '21: -32.3M Q3 '21: -42.2M Q4 '21: -44.8M Q1 '22: -24.3M Q2 '22: -33.2M Q3 '22: -45.7M Q4 '22: -36.7M Q1 '23: -34.9M Q2 '23: -34.6M Q3 '23: -24.6M Q4 '23: -32.8M Q1 '24: -22.8M Q2 '24: -15.8M Q3 '24: -13.7M Q4 '24: -17.5M Q1 '25: -20.2M Q2 '25: -37.1M Q3 '25: -17.5M Q4 '25: -86.1M Q1 '26: -106.5M Q2 '26: -36.5M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-120M -80M -40M 0 40M 80M 120M Q1 '18: -12.2M Q2 '18: -19.3M Q3 '18: -16.9M Q4 '18: -13.6M Q1 '19: -13.7M Q2 '19: -10.7M Q3 '19: -21.4M Q4 '19: -14.3M Q1 '20: -17.5M Q2 '20: -27.2M Q3 '20: -27.3M Q4 '20: -43M Q1 '21: -28.4M Q2 '21: -35.8M Q3 '21: -40M Q4 '21: -49M Q1 '22: -22.5M Q2 '22: -33.4M Q3 '22: -45.7M Q4 '22: -35.8M Q1 '23: -33.2M Q2 '23: -32.6M Q3 '23: -22M Q4 '23: -30.3M Q1 '24: -20.6M Q2 '24: -13.5M Q3 '24: -14.7M Q4 '24: -20.7M Q1 '25: -23.7M Q2 '25: -41M Q3 '25: -22.2M Q4 '25: -91M Q1 '26: -111M Q2 '26: -40.5M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 20M 40M 60M Q1 '18: 11.6M Q2 '18: 12.5M Q3 '18: 17M Q4 '18: 18.7M Q1 '19: 17.3M Q2 '19: 17.7M Q3 '19: 18.6M Q4 '19: 21.7M Q1 '20: 24.1M Q2 '20: 23.1M Q3 '20: 24.4M Q4 '20: 26.5M Q1 '21: 27.3M Q2 '21: 30.1M Q3 '21: 33.1M Q4 '21: 33.9M Q1 '22: 34M Q2 '22: 34.6M Q3 '22: 36.3M Q4 '22: 38.1M Q1 '23: 38.3M Q2 '23: 39.4M Q3 '23: 41.8M Q4 '23: 44.6M Q1 '24: 38.5M Q2 '24: 40.1M Q3 '24: 42.3M Q4 '24: 44.9M Q1 '25: 43.2M Q2 '25: 42.5M Q3 '25: 38.5M Q4 '25: 35.3M Q1 '26: 35.3M Q2 '26: 35.6M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '18: -5.9M Q4 '18: -13M Q1 '19: -5.2M Q2 '19: -8.4M Q3 '19: -5.5M Q4 '19: -13.1M Q1 '20: -16.8M Q2 '20: -751K Q3 '20: -4.5M Q4 '20: -4.1M Q1 '21: -3.1M Q2 '21: -4.8M Q3 '21: -5.4M Q4 '21: -9.8M Q1 '22: 1.2M Q2 '22: -9.6M Q3 '22: -12M Q4 '22: -14.8M Q1 '23: -5.6M Q2 '23: -11.6M Q3 '23: 3.1M Q4 '23: -19M Q1 '24: 10.3M Q2 '24: 1.6M Q3 '24: 6.2M Q1 '25: 280K Q2 '25: -9M Q3 '25: -464K Q1 '26: 18.5M Q2 '26: 275K Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '18: -6.1M Q4 '18: -14.3M Q1 '19: -5.9M Q2 '19: -8.8M Q3 '19: -6.1M Q4 '19: -13.4M Q1 '20: -17.2M Q2 '20: -1.1M Q3 '20: -5M Q4 '20: -10.6M Q1 '21: -9M Q2 '21: -7.1M Q3 '21: -7M Q4 '21: -10.4M Q1 '22: 802K Q2 '22: -9.8M Q3 '22: -13.2M Q4 '22: -15.2M Q1 '23: -6M Q2 '23: -12M Q3 '23: 3M Q4 '23: -19.3M Q1 '24: 10.1M Q2 '24: 1.3M Q3 '24: 5.5M Q1 '25: -390K Q2 '25: -9.2M Q3 '25: -719K Q1 '26: 18.2M Q2 '26: -70K Q4 '18 Q4 '19 Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 37.1M Q2 '20: 38.1M Q3 '20: 40.3M Q1 '21: 43.9M Q2 '21: 44.9M Q3 '21: 49M Q1 '22: 53.2M Q2 '22: 53.7M Q3 '22: 54.3M Q1 '23: 55.5M Q2 '23: 56M Q3 '23: 56.7M Q1 '24: 58.6M Q2 '24: 59.3M Q3 '24: 60.4M Q1 '25: 68.6M Q2 '25: 69.6M Q3 '25: 70.4M Q1 '26: 72.6M Q2 '26: 74M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '18: -23.76 Q1 '19: -39.65 Q2 '19: -58.10 Q3 '19: -55.79 Q4 '19: -12.86 Q1 '20: 2.88 Q2 '20: 24.15 Q3 '20: 24.87 Q4 '20: -2.90 Q1 '21: -3.08 Q2 '21: -3.17 Q3 '21: -3.31 Q4 '21: -3.23 Q1 '22: -3.12 Q2 '22: -2.94 Q3 '22: -2.96 Q4 '22: -2.66 Q1 '23: -2.72 Q2 '23: -2.68 Q3 '23: -2.23 Q4 '23: -2.09 Q1 '24: -1.84 Q2 '24: -1.49 Q3 '24: -1.34 Q4 '24: -1.15 Q1 '25: -1.15 Q2 '25: -1.51 Q3 '25: -1.59 Q4 '25: -2.56 Q1 '26: -3.74 Q2 '26: -3.70 Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.